GLP-1 receptor agonists like semaglutide have become some of the most prescribed drugs in the country for type 2 diabetes and weight loss. Most people tolerate them well, but a smaller number have reported serious digestive problems, and some of those reports have drawn regulatory attention and lawsuits. If you take one of these drugs, it helps to know which symptoms are routine, which ones call for a doctor, and what the research has and hasn't shown so far.
Published on:
October 12, 2026
Category:
Health Resources
GLP-1 receptor agonists mimic a gut hormone that helps control blood sugar and appetite. The best known is semaglutide, sold as Ozempic and Rybelsus for type 2 diabetes and as Wegovy for weight management; tirzepatide (Mounjaro, Zepbound) and liraglutide (Victoza) are others. Part of how they work is by slowing the rate at which the stomach empties, which curbs hunger and steadies blood sugar. That same slowing is also why most of the reported side effects show up in the gut.
Most GLP-1 side effects are digestive and mild: nausea, vomiting, diarrhea, constipation, and stomach pain, usually occurring in the first few weeks or after a dose increase. For a lot of people, they fade as the body adjusts. But some patients have reported worse or longer-lasting problems, like vomiting that won't stop, sharp abdominal pain, and not being able to keep food down. Specifically for semaglutide, the label also lists gallbladder issues, such as gallstones. When symptoms get that severe, or just don't ease up, they're worth getting checked rather than waiting out.
Because these drugs slow the digestive tract, a few serious conditions have drawn the most attention. Gastroparesis, sometimes called Ozempic stomach paralysis, is when the stomach empties far too slowly, leaving people bloated and nauseated and sometimes throwing up food eaten hours earlier. Ileus is when the intestines stop pushing contents along, and a bowel obstruction is a blockage; both can be dangerous. A 2023 research letter in JAMA examined people taking semaglutide or liraglutide (two GLP-1 drugs) for weight loss and compared them with those on a different type of weight-loss medication. There were higher rates of bowel obstruction and gastroparesis, and pancreatitis among those patients taking the GLP-1 drugs. The authors made it clear that these events are fairly rare and that the study shows only an association; there is no proof of causation.
In September 2023, the FDA added ileus to the Ozempic label under postmarketing experience, noting that voluntary reports can't always pin down a cause. Some case reports have also described small-bowel obstruction in people on semaglutide, sometimes tied to slowed transit or a bezoar, a mass of undigested material. Gastroparesis is worth extra care because in some people it can linger after the drug is stopped, and GLP-1 drugs generally aren't advised for anyone who already has it. None of this means the problems are common. It means the same slowdown that makes these drugs work can, for a small number of people, turn into something serious.
Some red flags shouldn't wait. Seek medical care right away for severe or lasting belly pain, vomiting you can't stop or trouble keeping fluids down, a swollen or hard abdomen, no bowel movements or gas, or signs of dehydration. Steady, severe pain high in the abdomen that spreads to the back, with or without vomiting, can be a sign of pancreatitis and needs urgent care. None of this automatically means a GLP-1 drug caused the problem, but these are the symptoms a doctor should check fast, not next week.
If your digestive symptoms are severe or do not improve, call your prescriber before you change any of your medications yourself. Be sure to mention any history of gastroparesis, past abdominal surgery, or other stomach and bowel problems. Ask about when to take your medication, whether easing up the dose more slowly would help, and which symptoms mean you should head to urgent care. And if you have surgery or a procedure with anesthesia coming up, tell your doctor you're on a GLP-1 drug, because slowed stomach emptying can increase the risk of aspirating food into the lungs. Whether to stop or switch is a decision to make together, not alone. Write down when symptoms started, how they lined up with a dose change, and any urgent care visits so your doctor has the necessary information.
A serious digestive injury can be painful and sometimes lasting. If you're trying to make sense of a possible GLP-1 gastrointestinal injury, the clearest first step is a conversation with your doctor about what happened and why. And if you or someone you love had a serious stomach or bowel problem while taking Ozempic, Wegovy, or another GLP-1 drug, Injury Info lays out what's known in plain terms and can help you figure out where to turn next. Take a look when you’re ready.
Learn why second medical opinions matter for serious illnesses. Know how to prepare, what to expect, and how to make confident healthcare decisions.
Learn how environmental health studies evaluate paraquat in soil, water, and nearby communities, and how researchers interpret exposure data.
Can hair relaxers cause cancer? See what NIH-funded research reports about hair relaxer cancer risk, what it doesn't report, and when to see a doctor.
© 2026, Injury Info. All rights reserved.